期刊文献+

真核表达载体pEGFP-GPC3的构建及表达 被引量:1

Construction and expression of eukaryotic expression vector for pEGFP-GPC3
原文传递
导出
摘要 目的:构建磷脂酰肌醇蛋白聚糖3(GPC3)真核表达载体pEGFP-GPC3,并在小鼠树突状细胞(DC)表达。方法:将质粒pCMV-SPORT6-GPC3和载体pEGFP-N1分别进行双酶切获得目的基因GPC3片段和空载体,回收纯化后用T4连接酶将两者连接并转化E.coli DH5α菌株,用EcoR I、BamH I双酶切鉴定后通过脂质体法转染到DC中,然后进行荧光检测和Western blot分析。结果:构建的真核表达载体pEGFP-GPC3,转染DC后,荧光显微镜下可见转染的DC中有EGFP-GPC3融合蛋白的表达,Western blot分析发现有相对分子质量(Mr)大小约为67 000的蛋白条带。结论:成功地构建了真核表达载体pEGFP-GPC3并在转染DC后能在其中表达,为进一步研究GPC3基因的功能提供实验基础。 AIM: To construct and expression of eukaryotic expression vector of glypican-3 (GPC3) pEGFP- GPC3 in mouse dendritic ceils (DCs). METHODS: The target gene fragment of GPC3 and empty vector were obtained from plasmid pCMV-SPORT6-GPC3 and vector pEGFP-NI digested by double enzymes. GPC3 and empty vector were linked by ligase T4, and then transfected into E. coli DHSa. Identification with EcoR I, BamH I digestion, the recombinant eukaryotic expression vector pEGFP-GPC3 was transfected into DCs by LipofectamineTM2000. Fluores- cent microscopy and Western blot were used to detected the expression of GPC3. RESULTS: The expression of EGFP- GPC3 fusion protein was detected in DCs, and GPC3 fusion protein of 67 kDa was detected by Western blotting. CON- CLUSION: The eukaryotic expression vector pEGFP-of GPC3 was constructed succesfully and transfected effectively into DCs.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第5期462-465,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 广西医疗卫生重点科研课题(重200611) 广西科学研究与技术开发计划项目(桂科攻0719006-2-5) 广西科学基金(桂科自0728196)
关键词 GPC3 EGFP 真核表达 树突状细胞 GPC3 EGFP eukaryotic expression den-dritic ceils
  • 相关文献

参考文献1

二级参考文献3

共引文献52

同被引文献10

  • 1Filmus J, Church JG, Buick RN. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine[ J]. Mol Cell Biol, 1988, 8(10) : 4243 -4249.
  • 2Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy [J]. EurJCancer, 2011,47(3): 333-338.
  • 3Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma [ J ]. Cancer Sci, 2009, 100(8): 1403-1407.
  • 4Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma[J]. Mod Pathol, 2005, 18(12): 1591-1598.
  • 5Yasuda E, Kumada T, Toyoda H, et al. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypi- can-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma [ J ]. Hepatol Res, 2010, 40 ( 5 ) : 477 - 485.
  • 6Feng M, Kim H, Phung Y, et al. Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro [ J ]. Int J Cancer, 2011, 128(9) : 2246 -2247.
  • 7De Cat B, MuyldeImans SY, Coomans C, et al. Processing by propm- tein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements [ J ]. J Cell Biol, 2003, 163 ( 3 ) : 625 - 635.
  • 8Allegretta M, Filmus J. Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma [ J ]. Antieancer Agents Med Chem, 2011,11(6) : 543 -548.
  • 9Huber R, Crisponi L, Mazzarella R. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5 '-promoter and 3'- terminal ends of the human glypican 3 (GPC3) gene[ J]. Genomics, 1997, 45(1) : 48 -58.
  • 10凌永赤,方天敏,刘宁,赵荫农.GPC3真核表达载体的构建及其对肝癌细胞功能的影响[J].广西医科大学学报,2011,28(3):348-351. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部